Sambrinvest

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

AdipoPharma SAS is a biotechnology company focused on exploring the role of adipocyte cells in diabetes management. It develops peptide-based drugs aimed at treating insulin resistance, type 2 diabetes, and associated comorbidities. The company conducts in-depth genetic investigations, particularly related to Alström syndrome, utilizing a therapeutic approach that targets specific cellular mechanisms. By examining the complex functions of adipocytes and their effects on lipid metabolism, AdipoPharma seeks to restore healthy lipid biosynthesis in diseased adipocytes. This targeted method aims to enhance insulin sensitivity, facilitate the removal of beta-cell plaques, and reduce liver steatosis and fibrosis, ultimately providing low-risk treatment options for diabetes patients.

AbolerIS Pharma is a biotechnology company based in Nantes, France, specializing in the development of immune-modulators aimed at treating transplant rejection, graft-versus-host disease, and autoimmune diseases. Incorporated in 2019, the company offers innovative products such as Anti-CD45RC, a monoclonal antibody designed to deplete effector T cells, and IL-34, a cytokine that promotes the induction of tolerogenic macrophages and regulatory T cells. AbolerIS Pharma employs a unique therapeutic approach that fosters immune tolerance while preserving beneficial immune responses in the context of inflammatory, autoimmune, and degenerative diseases. This strategy allows the company to focus on advancing novel drugs to address significant unmet medical needs in these therapeutic areas.

Cikisi is a company that specializes in Web Intelligence, focusing on the collection, searching, and filtering of web information to help organizations leverage relevant data for their growth. It develops and commercializes the Cikisi WMT, a Web Intelligence Solution designed to provide real-time, tailored market insights. By utilizing artificial intelligence, Cikisi's software simplifies and optimizes the processes of gathering, processing, and disseminating pertinent information, thereby enabling companies to accelerate their decision-making. Through its innovative solutions, Cikisi aims to enhance the effectiveness of businesses in navigating the complexities of the digital information landscape.

Santero Therapeutics is a biopharmaceutical company focused on developing innovative antibiotics aimed at addressing the challenge of multi-drug-resistant pathogens. The company concentrates on creating novel medications that utilize fresh modes of action to effectively combat diseases with high resistance, particularly in the realm of antibiotic-resistant microorganisms. Santero's products are designed to offer prolonged efficacy, reducing the likelihood of new resistance emerging and providing patients with better-tolerated treatment options for complex infections. Through its commitment to advancing antimicrobial therapies, Santero Therapeutics aims to improve patient outcomes in the face of rising antibiotic resistance.

Sunrise is a medical technology company focused on improving the diagnosis and management of sleep disorders, particularly sleep apnea, which affects nearly one billion people worldwide. The company has developed a 3-gram sensor that allows for rapid and accurate at-home diagnosis of sleep conditions, utilizing trigeminal drive analysis to detect respiratory events. This innovative device is clinically validated for use in both adults and children and provides a cost-effective alternative to traditional in-lab sleep studies. Users receive a single-use sensor delivered to their home, which connects easily to their phone for seamless operation. Following the test, Sunrise facilitates consultations with certified sleep doctors or connections to local sleep centers, addressing a critical need in a healthcare landscape where 80% of sleep apnea cases remain undiagnosed.

Exthand is a developer of open banking solutions that provides clients with access to a single API connecting to the APIs of 95% of banks in Europe, the UK, and Israel. This connectivity enables instant account-to-account payments and facilitates the retrieval of data from bank accounts. Exthand's offerings can enhance various financial processes, including personal finance management, credit scoring, and cash flow management. By leveraging these capabilities, businesses can benefit from faster and more cost-effective payment solutions while streamlining their accountancy and financial operations.

Aerospacelab SA, founded in 2017 and headquartered in Mont-Saint-Guibert, Belgium, specializes in the development and manufacture of small satellites equipped with advanced sensors. The company focuses on creating satellite imagery technology that captures high-resolution optical data, allowing for frequent data collection. In addition to satellite production, Aerospacelab develops tools that utilize artificial intelligence and machine learning to automate various tasks, facilitating processes such as surveying and monitoring. This innovative approach enables customers to efficiently analyze substantial volumes of data and optimize the extraction of valuable insights from the information gathered.

Cake App mission is to become the leading software technology provider that analyzes financial data to help people better understand, control and improve their finances, supported by a business model that shares our revenue with users.

HeartKinetics is a company that focuses on developing artificial intelligence solutions for the rapid and precise detection of heart failure and cardio-toxicity. Utilizing a network of nine AI models trained on data from thousands of patients at the Mayo Clinic, HeartKinetics can assess cardiac mechanical and electrical functions in minutes. The company's technology includes motion sensors embedded in Holter ECG patches, which aim to predict cardiac complications and facilitate quicker therapeutic decisions. Additionally, HeartKinetics offers a cloud-based platform that transforms data into predictive insights for treatment efficacy, enabling healthcare professionals to provide personalized care based on individual patient needs.

PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, specializing in the development of innovative active immunotherapies for cancer. The company utilizes a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells (PDC*line) that are loaded with cancer antigens to enhance the immune response against tumors. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, PDC*line Pharma evolved from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. The company aims to provide more effective cancer treatments by leveraging these potent and scalable dendritic cell lines to boost antitumor responses, including those targeting neoantigens, and to stimulate specific cytotoxic T-cell activity beyond what conventional vaccines can achieve. Eric Halioua joined the company in 2016 and has since served as President and CEO, guiding its progression into clinical development.

HireRing is an on-demand staffing platform that connects employers with specialized recruitment agencies tailored to their specific hiring needs. By allowing employers to submit vacancy requests and set upfront hiring fees, the platform streamlines the recruitment process. This efficiency enables recruitment agencies to quickly identify and select suitable business opportunities, ensuring that employers receive quality service from qualified professionals. Through its marketplace model, HireRing facilitates a seamless interaction between employers and recruiters, enhancing the overall hiring experience.

EsoBiotec is a Belgian biotechnology company dedicated to the discovery of innovative cancer therapies. The firm specializes in immunotherapies that aim to empower the human body to combat cancer through in vivo cell engineering. EsoBiotec focuses on developing cost-effective drugs and therapeutics, ensuring that patients have access to essential cancer treatments at lower costs. By prioritizing accessibility, the company seeks to improve the overall effectiveness of cancer care and enhance patient outcomes.

Sortlist is a company that develops an online multi-criteria searching tool designed to assist businesses in finding suitable marketing and communication agencies. By leveraging professional networks and peer-to-peer recommendations, Sortlist enables marketing managers to efficiently discover potential partners in a rapidly evolving digital landscape. The platform caters to businesses of all sizes and sectors, streamlining the process of identifying service providers that align with specific needs and criteria. This solution allows clients to focus on enhancing their communication and marketing efforts rather than spending excessive time searching for the right agency.

Amyl Therapeutics is a preclinical stage biotechnology company focused on developing innovative therapeutics for the treatment of amyloidosis and related neurodegenerative diseases. The company employs a novel mechanism to target and bind to the amyloid folds of toxic protein aggregates, including those associated with conditions like systemic amyloidosis and neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. By addressing misfolded proteins, including antibody light chain and transthyretin aggregates, as well as amyloid-β, Tau, and α-synuclein aggregates, Amyl Therapeutics aims to provide effective treatments that can prevent the accumulation of these harmful proteins in both peripheral organs and the brain. This approach offers the potential for significant advancements in managing diseases related to protein misfolding.

Shyfter is a comprehensive scheduling platform designed to optimize workforce management across various industries. The platform allows companies to create and adjust employee schedules while utilizing AI-driven productivity calculations to ensure optimal staffing levels. Key features include real-time time tracking, absence management, and effective communication tools, enabling teams to coordinate efficiently. Shyfter's user-friendly interface empowers managers to quickly respond to staffing changes, approve leave requests, and maintain compliance with work hours regulations. By automating routine scheduling tasks, the platform reduces administrative burdens, minimizes conflicts, and enhances overall productivity. Additionally, Shyfter provides advanced analytics that deliver insights into workforce trends, supporting businesses in making informed, data-driven decisions. Customizable for small to medium-sized enterprises, Shyfter serves as an essential tool for effective workforce management, tailored to meet specific organizational needs.

ExeVir Bio BV is a Belgian biotechnology company founded in 2020 and headquartered in Zwijnaarde. The company specializes in developing single-domain antibody-based therapies aimed at preventing viral infections. Utilizing a llama-derived antibody technology platform, ExeVir Bio focuses on creating robust antiviral treatments, particularly targeting coronaviruses. One of its key products, VHH72-FC, binds to a conserved region of the SARS-CoV-2 spike protein, which is crucial for the virus's entry into human cells. The company has established a rapid response platform for antivirals, allowing for a quick adaptation to emerging health threats through a streamlined process for generating drug candidates. Their protein-based therapeutics are designed to be stable, cost-effective, and accessible on a global scale, addressing significant public health challenges posed by viral infections.

OncoDNA is a theranostic and genomic company that specializes in precision medicine for cancer and genetic diseases. Founded by a team with over 60 years of experience in medical diagnostics, the company focuses on providing clinical guidance for the treatment and real-time monitoring of late-stage cancer patients. OncoDNA supports researchers and biopharma companies in navigating the complexities of molecular biology, facilitating research and drug development in oncology. With its commitment to delivering precision medicine, OncoDNA aims to enhance treatment outcomes and improve the management of cancer and genetic disorders.

PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, specializing in the development of innovative active immunotherapies for cancer. The company utilizes a proprietary allogeneic cell line of Plasmacytoid Dendritic Cells (PDC*line) that are loaded with cancer antigens to enhance the immune response against tumors. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, PDC*line Pharma evolved from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. The company aims to provide more effective cancer treatments by leveraging these potent and scalable dendritic cell lines to boost antitumor responses, including those targeting neoantigens, and to stimulate specific cytotoxic T-cell activity beyond what conventional vaccines can achieve. Eric Halioua joined the company in 2016 and has since served as President and CEO, guiding its progression into clinical development.

Utopix Pictures SA is a Belgium-based company founded in 2015, specializing in connecting clients with professionals in the photography, film, and image industries. Operating from Mont-Saint-Guibert, Utopix Pictures provides a platform designed to streamline the process of finding the right photographer or videographer for various business projects. The company emphasizes the importance of visual content in effectively conveying ideas and aims to facilitate the quick and easy selection of skilled professionals who can turn concepts into compelling images.

Cognivia is a company that focuses on developing analytical tools aimed at optimizing and accelerating the clinical development of new medicines. Its innovative tools employ predictive techniques to enhance the clinical evaluation of drugs and other therapeutics. By addressing and mitigating the variability in clinical trial data, Cognivia enables its clients to identify and manage critical sources of variability, ultimately improving the efficiency and effectiveness of clinical trials.

Smartbeam is a construction-tech platform focused on enhancing collaboration among stakeholders in real estate construction projects while improving financial oversight on construction sites. The company offers features such as automated data collection and analysis, along with real-time budget tracking, which collectively streamline workflows from the pre-construction phase through to completion. By providing robust budget management tools, Smartbeam aims to increase project efficiency, reduce rework, and boost productivity. The platform is designed to enhance the reliability of budgets and minimize financial risks, ultimately supporting construction professionals in managing their projects more effectively.

Djengo is a technology company specializing in smart parking management and green mobility solutions for businesses. Its flagship product, Commuty, is designed to optimize corporate parking, mobility, and office space through an automated reservation system. Djengo's services cater to a diverse range of users, including visitors, individuals with reduced mobility, carpoolers, cyclists, and electric vehicle owners. In addition to parking management, Djengo also offers a ridesharing platform that facilitates peer-to-peer ridesharing and carpooling for home-to-work commuting. By integrating these services, Djengo aims to enhance the efficiency of urban mobility and promote sustainable transportation solutions for companies.

Commuty, established in 2014 and headquartered in Louvain-la-Neuve, Belgium, specializes in developing a web and mobile application for parking and mobility management. The company's primary service is a smart parking management platform that organizes company-managed parking spot allocations and bookings according to specific parking policies. Additionally, Commuty offers bicycle sharing services that connect cyclists with similar routes and automate kilometer refunds. Furthermore, the company facilitates ride-sharing arrangements, automating tax advantages and ensuring guaranteed returns for riders. Through these services, Commuty helps businesses save money while promoting flexible and sustainable mobility options.

Sortlist is a company that develops an online multi-criteria searching tool designed to assist businesses in finding suitable marketing and communication agencies. By leveraging professional networks and peer-to-peer recommendations, Sortlist enables marketing managers to efficiently discover potential partners in a rapidly evolving digital landscape. The platform caters to businesses of all sizes and sectors, streamlining the process of identifying service providers that align with specific needs and criteria. This solution allows clients to focus on enhancing their communication and marketing efforts rather than spending excessive time searching for the right agency.

Minoryx Therapeutics is a biotechnology company based in Mataro, Spain, founded in 2011. The company specializes in discovering and developing innovative treatments for life-threatening rare diseases, with a particular focus on pediatric neurometabolic conditions of genetic origin. Minoryx is known for its development of pharmacological chaperones, a new generation of small molecule drugs designed to restore protein functionality, thereby addressing unmet medical needs in genetic diseases that severely affect the central nervous system. Additionally, Minoryx engages in repositioning-based projects to explore alternative therapeutic options for these challenging conditions.

ChromaCure is a biotechnology company focused on developing innovative cancer therapies. The company specializes in discovering first-in-class small molecule therapeutics that address unmet needs in oncology. ChromaCure's primary goal is to identify potential new drug candidates that selectively and potently inhibit cancer targets, offering novel treatment options for various forms of cancer. These therapies are designed to be used either as monotherapy or in combination with existing treatments such as immunotherapy or chemotherapy, aiming to provide more effective solutions for cancer patients.

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. Utilizing human induced pluripotent stem cell (hiPSC) technology, Ncardia develops predictive human cellular assay systems that facilitate safety and efficacy testing of drug candidates. The company's innovations enhance cardiovascular and neural drug screening, allowing researchers and drug discovery firms to incorporate predictive human disease biology into their processes. Through its advanced technologies, Ncardia aims to accelerate the overall drug discovery timeline, ultimately improving the efficiency and effectiveness of bringing new therapeutics to market.

Ncardia is a biotechnology company focused on expediting the drug discovery and development process. Utilizing human induced pluripotent stem cell (hiPSC) technology, Ncardia develops predictive human cellular assay systems that facilitate safety and efficacy testing of drug candidates. The company's innovations enhance cardiovascular and neural drug screening, allowing researchers and drug discovery firms to incorporate predictive human disease biology into their processes. Through its advanced technologies, Ncardia aims to accelerate the overall drug discovery timeline, ultimately improving the efficiency and effectiveness of bringing new therapeutics to market.

Opinum is a Belgian company based in Braine l'Alleud, specializing in hardware technologies and digital solutions for the energy and environmental sectors. It has developed the Opinum Data Hub, a platform designed to facilitate the digital transformation of organizations involved in energy management. The platform encompasses the entire data management value chain, allowing users to navigate complex data while focusing on their core competencies. Opinum's software enables businesses to analyze and visualize energy and environmental data, effectively tracking and regulating the consumption of resources such as gas, water, and electricity. Its primary clients include large private and public service companies, energy suppliers, and energy services companies (ESCOs).

X4C specializes in developing advanced monolayer chemical coating technology for a variety of life science applications. The company creates molecular coatings tailored for in vitro diagnostics, medical devices, electronics, and optics. X4C's innovative platform employs a unique approach to surface coating that allows for the precise grafting of robust organic monolayers. This technology enables healthcare professionals to impart specific functionalities to substrates while maintaining their inherent properties. Additionally, X4C offers a range of products, including nanoparticles and calixarenes, along with customized services to meet the diverse needs of its clients in the life sciences sector.

Opinum is a Belgian company based in Braine l'Alleud, specializing in hardware technologies and digital solutions for the energy and environmental sectors. It has developed the Opinum Data Hub, a platform designed to facilitate the digital transformation of organizations involved in energy management. The platform encompasses the entire data management value chain, allowing users to navigate complex data while focusing on their core competencies. Opinum's software enables businesses to analyze and visualize energy and environmental data, effectively tracking and regulating the consumption of resources such as gas, water, and electricity. Its primary clients include large private and public service companies, energy suppliers, and energy services companies (ESCOs).

Opinum is a Belgian company based in Braine l'Alleud, specializing in hardware technologies and digital solutions for the energy and environmental sectors. It has developed the Opinum Data Hub, a platform designed to facilitate the digital transformation of organizations involved in energy management. The platform encompasses the entire data management value chain, allowing users to navigate complex data while focusing on their core competencies. Opinum's software enables businesses to analyze and visualize energy and environmental data, effectively tracking and regulating the consumption of resources such as gas, water, and electricity. Its primary clients include large private and public service companies, energy suppliers, and energy services companies (ESCOs).

Calyos is a company specializing in thermal regulation systems, focusing on advanced loop heat pipe cooling products. Originating from the space industry, Calyos leverages its expertise and scalable manufacturing capabilities alongside patented technologies to provide innovative cooling solutions. The company's systems utilize a dielectric fluid that absorbs heat and vaporizes at low temperatures, allowing clients to effectively manage heat in high-performance electronics across diverse applications, including servers, renewable energy systems, and telecommunications equipment. By enabling designers to create products without thermal limitations, Calyos aims to enhance the competitiveness of its clients' offerings in the market.